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We report on a patient with cutaneous T-cell lytn-
phoma (CTCL) of long-standing duration. Pheno-
typic analysis of his peripheral blood mononuclear 
cells revealed an increased CD4 + T -helper subset and 
a decreased CDS + cytotoxic T-cell population. 
Eighty-three to ninety-three percent of the patient's 
CD4 + T cells in the peripheral blood and 70% of the 
CD4 + T cells in the lesional skin lacked surface 
expression of the TCRlCD3 complex and showed a 
clonal rearrangement pattern of the TCR gamma-
chain gene (V11-J1 /J2). The lack in TCR surface 
expression correlated with defective assembly of the 
TCR beta-chain. Although mRNA for the TCR con-
C utaneou s T cell lympho ma (CTCL), a low-grade n o n-Ho dgkin 's lymph o ma , is charac te ri zed b y a c1o.nal prolife ratio n ofT lymphocytes, m os tl y of th e h elper- indu cer phenotype (CD4 +TCR + CD3 + CD2 + C D 45ll...O + ) [1] . T h ese n eoplastic T lympho-
cyte s have a predilec tio n for the e pide rmis and papillary d e rmis ill 
the e arly stages of th e disease. Involvement of lymph n o d es, 
p e riphe ral bloo d , and visceral o rga n s is the pre d o minant fea ture of 
later stages of CTCL. C haracteristic immunologic abnorma lities in 
the advanced stage of CTCL include re du ced T-cell respon siven ess 
to antigens a nd mitogen s, impaire d natural kille r cell activi ty, 
eosinophilia and increased le v e ls of immunoglobulin s of th e IgE 
and JgA isotyp e [1] . 
T h e c urre nt study presents a patie nt with CTCL and a stable 
c hronic course of th e disease. Initia l evaluatio n of the patient's 
p e riphe ral blood mOllo nuclear cells (FBMC) and m o nonuclear cell s 
(MN C ) from les io n al skin revea led th e predominan ce of T lym-
phocytes w ith an unusual T-helpe r cell phe notype lackin g surf:lce 
expression of both the T-cell receptor (TCR) alpha / b e ta and TCR 
g amma/ d e lta CD3 complex. T h e aim of the presen t study was to 
inves tig ate the na t ure of t h e d efect in TCR /CD3 surf.'1ce e xpression 
of the patie nt' s T cells and its effect o n cell function. 
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Abbreviation: MN C : mononuclea r cells. 
stant region /31 was found in the p a tient's purified 
CD4+TCR- CD3 - T cells, no intracytoplasmic TCR 
beta protein was detectable. In contrast, the patient's 
purified CD4+TCR- CD3- T cells not only expressed 
mRNA specific for the TCR alpha-chain and for all 
CD3 chains, but intracytoplasmic TCR alpha and 
CD3 epsilon proteins could also be found. The lack of 
TCR beta protein clearly explains the defective sur-
face expression of the TCRlCD3 complex in the 
patient's malignant T cells. KeJl lIJol,ds: I'evel'se t l'all-
sCI'iptase-polJlmera.se chain I'eactioll tecl",ique/TCR gamma 
cllaill I'earrallgemellt. ] Illvest D ermatol104:537-540, 1995 
MATEIU ALS AND METHODS 
Patient Description We report on a 47-year-old white man with 
CTCL of long-term duration . His skin showed confluent background 
erythema with rcticulate hyperpigmenration and telangiectasia, suggestive 
of poikiloderma atrophicans vasculare. Histology of typica l lesions showed 
an ep idcrmotropic infil trate with characte ristic Pautriere microabscesses. A 
lymph- node biopsy revealed demlatopathic lymphadenopathy. and the 
bone marrow was tice of atypica l lymphocytes. Ini tia l immune hematologic 
studies showed an increased CD4 + and a decreased CDS + T-ce ll popula-
tion , and Sezary cell counts wcre less than 10'l/ •. Serum IgE levels were 
higher than 10000 IU / ml. R epeated viro logic eva luation was negative for 
human T-ce ll Iymphotrophic virus-1, human T-cell Iymphotrophic virus-2. 
human immunodeficiency virus- I, human immunodeficiency virus-2. EBV 
and C M V. T he patient showcd no response to extracorporeal photoche-
motherapy and im erferon (IFN)-alpha 2a treatment [2] , except for a 
rcduction in the in tensity and freq uency of fever bouts after IFN-alpha 2a 
therapy. 
Isolation of PBMC, Separation of CD4 +TCR- CD3 - T cells, and 
Preparation of MNC From Lesional Skin rOMC were isolated fi·om 
heparini zed w hole blood by buoyant density gradient centrifugation (Lym-
phoprep. Nycomed Phanna. Oslo, Norway) [3]. T-enriched cell s were 
prepared by rosetting with sheep erythrocytes (cell purity was 95-9S% 
02+ cell s) 13] and malignam CD4 +TCR - CD3 - T cell s were purified by 
magnetic immunoselection (Dynabeads M450 . sheep anti-mouse IgG-
coa ted beads, Dynal, Oslo . Norway) by dep leting CD3-positive T cell s, 
natural kill e r cell s (CD56 +) and B ce ll s (CD19 +) from the patient's 
T -enriched population (ce ll puri ty was m ore than 95% CD4 + cell s and less 
than 0.2% CD3 + cells) . Epidermal MN s were isolated from lesional skin 
according to standard pro toco ls 14J. In brief. skin biopsies from the patiem's 
lesional skin were treated with co llagenase la (2000 U / ml. Sigma C hemi-
cals, t. Louis. MO). T he resul ting cell suspension was passed th rough 
gauze to remove large clumps ("iability. 80-90')1" by trypan blue exclusion) 
and subsequcntly centlifuged over a Lymphoprep density gradient. The 
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Table I. Phenotypic Analysis of the Patient's PBMC and 
MNC from Lesional Skin 
CD3 
TCRa/b 
TCRg/d 
C D4 
C D4+CD3 + 
C D4 +TCRa/b + 
CDS 
C D8+TC Ra/ b+ 
Percentage of Cells Expressing the Respective 
Marker l ! 
Controls 
Patient (n = 3)" 
PBM C MNC from les iona l skin j'BMC 
16 22 65 :':: 6 
13 29 62 :':: 4 
9 3 :':: 2 
77 65 43 :':: 6 
13 19 42 :':: 4 
13 20 41 :':: 5 
4 NO' 23 :':: 4 
4 NO 22 :':: 3 
" lmmuno phcnOl)'ping of periphe ral blood lymphocytes and lymphocytes from 
Icsio nal skin was performed by di.rcct rwo ... color immunofluore sce nce stain ing lIsing 
Ma Abs as described in Male";nls (l1If1 1\1ellwt/s. EVOIl uacioll wa s performed by flow 
cytometry, analyzing a total of 10,000 cells. 
" Control v;llucs represe nt three health y :Idu lts and arc expressed as rncan ± SEM . 
(' NO. not dete rmin ed . 
interphase was collected, washed, and analyzed by two-color Aow cytom-
etry (Table I) . 
Phenotypic Analysis PBMC were ana lyzed by direct two-color immu-
noAuorescence staining using the following monoclonal antibodies 
(MoAbs): Leu 5b (CD2), Leu 4 (CD3), Leu 3a (CD4), Leu 2a (CD8), 
TCR-1 alb, TCR-l gld, anti-interleukin-2R (CD25), Leu-45RO 
(C D4 5R O), Leu '\ (CD5), Leu 9 (CD7) (all from Becton Dickinson, San 
Jose, CAl , lOA 30 (C D30, Immunotech Jnt., Marse iJl e, Fran ce) , and 
BMA-031 (TCR alpha-beta, Boehringer Mannheim, Mannheim , Germa-
ny). 
Isolation of Genomic DNA and DNA-Polymerase Chain Reaction 
(PCR) Genomic DNA was isolated from the patient's peripheral blood 
C D4 +TCR - CD3 - T cells, the patient's normal and lesional skin, as we ll as 
from the controls' peripheral blood CD4 +TCR +CD3 + T cell s USiJlg 
standard protoco ls (5). PC R. ana lys is of genomic DNA was carried out with 
a mi.xture of primers specifi c for th e va riable (V) and joining 0) regions of 
the TCR gamma-chain gene segments (TCR V gamma 2, 3, 4, 5, 8, 9, 11 , 
12; TCR J gamma)GT 12, )GT3, JGT4; designed according to the recent 
work by T rainor el nl [6]). 
Semiquantitative Reverse Transcriptase PCR (RT-PCR), Hybrid-
ization and Densitometric Analysis Tota l ce l/ula r RNA was isolated 
from the patient's purified malignant CD4 +C D3 - TCR - T cell s and 
T-enriched ce ll s of two healthy controls, and was reverse-transcribed into 
cD NA (3) . The cD NA copies were then amp li fied using primer pairs 
specific for TCR alpha (C alpha, 5' pos itions 342-363 and 3' positions 
645-617 [7]), TCR beta (C/31, 5' positions 506-532 and 3' positions 
1038-1011 ; C/32, 5' positions 102- 128 and 3' positions 632-605 [8]), CD3 
gamma (5' positions 65-93 and 3' posi tions 569-544 [9]) , C D3 delta (5' 
positions 186-21 3 and 3' positions 579-533 [1 OJ), C D3 epsilon (5 ' 
pos itions 195-2 18 and 3' positions 697-673 [11]) , CD3 zeta (5 ' positions 
31-55 and 3' positions 614 -590 11 2 1) and glyceraldehyde-3-phosphate 
dehydrogenase (GAPOI-I) (5 ' positions 212-235 and 3' positions 798-809 
(1 3]) as described ea rlier [3]. The amplification program consisted of 30 
cycles of denaturation at 94°C fo r 1 min, primer annealing at 60°C for 2 
min , and extension at 72°C for 3 n'lin . The PC R-generated products wcre 
fractionated on 1.5%, aga rose ge ls and hybridized with internal o ligonucle-
otides ITC R alpha (positions 64 5-617 [7]) , TCR beta (C/31 positions 
'1038-'101 1 and Cf32 positions 632- 605 IS]) , CD3 gamma (positions 461-
433 19]) , C D3 delta (positions 468-438 (1 OJ), CD3 epsilon (positions 
476-445 (11), CD3 zeta (positions 614-590 [1 2]) and GAPDI-J (posi-
tions S09-7S6 [1 3])]. The relative densil:Y of the signals was detennined by 
image-ana lysing densi tometry [OO +MMJ (LKB Biotech., pdi Q uantity 
O ne, Uppsa la, Sweden). 
Detection of Intracytoplasmic TCRlCD3 Chains in tbe Patient's 
PBMC Air-dried cytocentrifuge smears were fix ed with acetone and 
incubated with an anti-CD3 epsilon-chain MoAb (VIT-3 b. kind ly provided 
by Dr. O. Majdic, Inslitute of Immun ology, Un iversity of Vienna , Austria), 
an anti-TCR alpha-chain MoAb (T-'''pha 1. T ce ll Science, Cambridge, 
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MA) or an anti-TCR beta-chain MoAb (T-betH l, T cell Science). Cells 
were stained with a Auorescein isothiocyanate- conjugated anti-mouse Ig 
(an der Grub, Bio Kesearch , Kaulllberg, Austria), washed and analyzed by 
imnlul1oAuorcsccncc lnicroscopy. 
RESULTS 
Immunologic Phenotype ofPBMC and MNC Isolated frOIn 
Lesional Skin Phenotypic analysis of the patient's PBMC re-
vealed an increased CD4 -I- lymphocyte population and a decrease in 
CD8 + cells (Table I). Eighty-three to nine ty-three percent of the 
CD4 + PBMC constantly lacke d surfilce expression of th e TCR 
alpha/beta and TCR gamma/delta CD3 complex, whereas 7-17% 
of CD4 + PBMC expressed the TCR/CD3 complex on the ir cell 
surface. Patient's peripheral blood CD4 + T cells e xpressed CD2, 
CDS, and CD4SRO, but not IL-2R, CD7, or CD30 «Z'Y.,) 011 
their cell surf.1ce. In contrast, all CD8 + cells expressed the TCRI 
CD3 complex. Ph e notypic analysis of MNC isolated from les iona l 
skin revealed that about 70% of the CD4 + T cells lacked surfa ce 
expression of th e TCR/CD3 complex, whereas the remaining 30% 
of CD4 + T cells had the TCR/CD3 complex o n their ce ll surface 
(Table I). 
Patient's CD4+TCR- CD3 - T Cells Show Clonotypic TCR 
Gamma Gene (Vll-JlIJ2) Rearrangement A distinct band of 
PCR-amplified products re presenting the TCR gamma Vl1-J 1IJ2 
gene rearrangement was found in the patient's purified m alignan t 
CD4 +TCR - CD3 - T cells isolated frOI11 pe ripheral blood and in 
lymphocytes £i'om lesional skin, indicating monoclonality (Fig 1, 
lalles 2 alld 3). As expected, no band ofPCR-amplified products was 
found in the patient' s normal skin (Fig 1, Inll e 4). In the controls' 
CD4 +TCR + CD3 + T cells, a broad smear of amplified rearranged 
products was indica tive for po lyclona li ty (Fig 1, Inll e 5). 
The Patient's CD4 + CD3 - TCR - T Cells Expressed Reduced 
TCR C{31 mRNA Levels and No TCR C{32 mRNA Semi-
quantitative RT-PCR reveal ed chat ml~A levels for TCR alpha-
chain and the various CD3 chains in the patient's purified 
CD4 + CD3 - TCR- T cells were comparable to those of the healthy 
controls (Fig 2). TCR C{3J mRNA w as detectable, although 
1 2 3 4 5 6 7 
~309 
~201 
F igure 1. Preferential TCR V g:lI11ma l1 -JI I) 2 rearrangement in the 
patient's lymphocytes from peripheral blood and les ion,,1 skin . Polyacryl-
amide gel electrophoresis of PC R-amplified genomic DNA was carried out 
using the primer mix 2 specific for the variable (V 5, 9, 10,1 '1) and joining 
01 / )2) regions of the TCR. gamll1a gene. Genomic DNA frol11 the paticnt's 
purified C04 +T R. - C D3 - T ce lls iso lated frol1l peripheral blood (/nlle 2), 
the patient's tumorous skin (Inlle 3) , and normal skin (lilli e 4), as well as 
genomic DNA from peripher:" blood CD4 +TCR+ CD3 " T cell s of a 
normal indi vidua l (lillie 5) . was ana lyzed. P R assayed without DNA 
template se rved as a nega tive control (In lle 6). On ly the TCR V-gamma 
11-:)1 /) 2 primer showed a rearrangement as depicted in Inll es 2 nlld 3. The 
molecular-weight marker (lnll es J IIlId 7) was pBR.3 22 digested with the 
restriction endonuclease Msp I (622 , 527,404 .309. 242,238 . 201. 190, and 
ISO), and the position o f the generated bands are indicated. 
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expression was abo ut 50% reduced, and no TCR C{32 mRNA was 
detectable (Fig 2) . 
The Defective Surface Expression of the TCRlCD3 Com-
plex on the Patient's CD4+CD3 - TCR- T Cells Results 
from a Lack of Intracytoplasmic TCR Beta-Chain Protein 
Immunoflu orescen ce analysis rev ealed that most (- 90%) of the 
patient's PBMC lacked and only a few cells (e.g. , the cell in the 
lower left corner of Fig 3C) expressed the intracytoplasmic TCR 
beta protein (Fig 3C), whereas normal levels of TCR alpha (Fig 
3A ) and CD3 eps ilo n protein (Fig 3E) were detectable. Examina-
tion of the patient's purified maEgnant CD4 +CD3 - TCR - T cells 
(data not shown) confirmed this finding. T hese results indicate that 
although mRNA for TCR beta was detectable, the protein was 
lacking, pointing to a post-transcriptional defect. 
DISCUSSION 
We report on a patient with CTCL who showed an aberran t 
T -helper cell population (CD4 +CD5 +CD2 +CD45RO "') in his 
peripheraJ blood and lesional skin , which lacked the TCR/CD3 
complex on the cell surface. T hese CD4 +TCR - CD3 - T-helper 
cells presented a clonal rearrangement pattern of the TCR gamma-
chain gene (V11-JI /J2). The defective TCR surface expression was 
associated with an impaired TCR beta- chain assembly. Intracyto-
plasmic stainin g of the aberrant T cells revealed a lack of TCR 
beta-chain protein , w hereas intracytoplasmic TCR alpha- and CD3 
epsilon-chain proteins w ere present. For a functional TCR alpha 
beta/CD3 complex expressed on the T - cell surface, an oEgomeric 
complex consistin g of seven different integral membrane proteins 
(TCR alpha and beta; CD3 gamma, delta, epsilo n , zeta, ,uld eta) 
has to be formed in the endoplasmic reticulum [1 4]. When specific 
TCR/CD3 chains are missing, sing le subunits and partial receptor 
_ Controls D CTCL 
(n=2) patient 
TCR C alpha 
TCR C1 beta 
TCR C2 beta 
CD3 gamma 
CD3 delta 
CD3 epsilon 
CD3 zeta 
o 50 100 150 
Densitometry (% of control) 
Figure 2. TCR bcta mRNA can be detected by densitometric quantitation 
ofRT-PCR analysis in the patient's malignant cell s. The rel ative density of 
the signals obtained by Southern blot analysis of the PCR-generated 
products were measured by image-analysis densitometry. T he densitometric 
reading of the signals for TCll alpha, TCll beta and CD3 gamma , CD3 
del ta, CD3 eps ilon, lind CD3 ze ta were related to the co rrespondi ng 
densitometric readi ng of the signal for the internal control GAPDH, and 
resul ts in the patient are presented as percentage of the average of two 
healthy controls. 
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F igure 3. Cytoccn trifuge smears of the CTCL patient's PBMC sta ined 
with MoAbs specific for the TCll alpha-, TCll beta-, and CD3 epsilon-
chains. Air-dried cytoccntrifuge smears of PBMC from the patient (lift 
COIIllIlIl, A, C, E) and a healthy individual (rigllf COllllllll B, D, F) were stained 
with MoAbs specific for TCR alpha-chain (A, B), TCR beta-chain (C, D), 
and CD3 epsilon-chain (E, F), as described in Mare,;a l, alld Metltol/s. MoAb 
binding was developed by indirect. imlllunofluorescence and evalua ted by 
fluorescence microscopy. 
complexes are retained in the endoplasmic reticulum as assembly 
in termediates and do not make their way to the plasma membrane 
[15]. As shown previously [16,17], immature thymocytes and 
mutants of T-cell lines, lacking one of the TCR/CD3 chains, 
accumulate the other TCR/CD3 chains in the cytoplasm and fail to 
express the TCR/CD3 complex on the ce ll surface. T hus, the lack 
of TCR beta protein in our patient's CD4 +CD3 - TCR - T cells 
clearly expla.ins the defective sUL'face expression of the TCR/CD3 
complex on the majority of the patient's CD4 + T cells. 
Semiquantitative R T -PCR analysis revealed that normal mRN A 
le vels ofTCR alpha and all CD3 chains w ere found in the patient's 
C D4 "' CD3 - TCR - T cells. Messenger RNA specific for TCR C{31 
was also detectable, altho ugh transcripts were reduced to 50% of 
the levels detected in healthy controls. Peripheral blood T cells of 
he,llthy individuals express equal levels ofTCR C{31 and TCR C{32 
mRNA, beca use they are polyclonal . As the patient's aberrant 
T-helper cells are monoclonal , a preferential TCR C{31 gene 
rearrangem en t is not surprising. These findings suggest that the lack 
of intracytoplasmic TCR beta-chain protein in the patient's maEg-
nant T cells is not due to a defect at the tnmscl;ptional level, as 
TCR beta-chain rearrangement was found (data not shown). 
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However, expression of a truncated message cannot be excluded at 
present. 
The lack of TCR/CD3 surface expression in the patient's 
malignant T -helper cells was accompanied by alterations in T -cell 
function. The patient's malignant T-helper cells failed to produce 
IL-2, IL-4, and IFN-gamma upon stimulation with mitogens (PHA, 
PWM) or 3nti-CD2 stimulation (data not shown) . T hese results are 
in agreement with previous studies, showing that surf.1ce expression 
of a fully assembled TCR/CD3 complex is req uired for normal 
mitogen response [18] or signaling via CD2 [19]. T hese findings 
explain the reduced response to mitogens and recall antigen in the 
patient's total PBL fraction (data not shown), reflecting the de-
creased numbers of T cells with the n0n113 I CD4 +TCR +CD3 + 
phenotype. 
The lack in TCR surface expression of the malignant T cells due 
to defective expression of the TCR beta-chain protein could be 
relevant for the pathophysiology and disease progression of CTCL 
in tlus patient. As these cells lack the TCR/CD3 complex 011 their 
surface they cannot be driven to proliferate ill situ by major 
histocompatibility complex class II-associated peptides indigenous 
to the epidernus [20] . Thus in this singula r patient the relative 
unresponsiveness of TCR-deflcient malignant T cells to activating 
stimuli could play a role in the slow progression of Ius disease, 
resultmg in a relatively benign clinical course over a period of more 
than 10 years. 
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